Inmed appoints dr. barry greenberg, johns hopkins university school of medicine, to its scientific advisory board

Vancouver, british columbia--(newsfile corp. - october 22, 2024) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of dr. barry greenberg to its scientific advisory board. dr. greenberg is the director of the alzheimer's disease translational center and an associate professor in the department of neurology at the johns hopkins university school of medicine.
INM Ratings Summary
INM Quant Ranking